Isolated clonal cytogenetic abnormalities after high-dose therapy. - Wikidata - awgldk - TriplyDB

Isolated clonal cytogenetic abnormalities after high-dose therapy.

Isolated clonal cytogenetic abnormalities after high-dose therapy.

http://www.wikidata.org/entity/Q34108964

about

Measurable residual disease testing in acute myeloid leukaemia.

P2860

Q30234914-5BD67D7F-ECE2-4912-A415-49D4DD8FD21C

P2860

Isolated clonal cytogenetic abnormalities after high-dose therapy.

http://www.wikidata.org/entity/Q34108964

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@ast

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@en

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@nl

type

label

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@ast

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@en

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@nl

prefLabel

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@ast

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@en

Isolated clonal cytogenetic abnormalities after high-dose therapy.

@nl

P1433

Q34108964-B3A9205D-8196-4A47-94E8-D77AFF499536

P1476

Q34108964-B883B022-E7EB-4068-8056-D66938A68508

P2093

Q34108964-17E6B561-5897-440A-8809-2592F15E5237

Q34108964-24DEE369-29C4-4C84-B2F3-0F6685660488

Q34108964-34F43CF3-AE2A-4479-858C-4CCB3D88458A

Q34108964-45EACFAB-660A-48C4-9F10-DA968DCDA757

Q34108964-BAB7EFCA-EE72-4844-AA4E-99E6141FDB4B

Q34108964-C8BE442D-5922-4F26-9676-97B8C4DA06C8

P2860

Q34108964-0A78C4E4-F25D-43DA-8E52-C1E704DECF70

Q34108964-160DF824-0F4A-47DB-B6AB-9FCB6E1F555E

Q34108964-1E18633C-2FCA-4C8C-8E0E-02C8F92DADF3

Q34108964-3E31F918-B09D-4A8F-A30C-6E3E0054DC13

Q34108964-50F5CC34-EA39-48BC-8E01-0B6E6D223684

Q34108964-5EE195E8-8A0C-4481-BAA9-DF0A8CA6A6B2

Q34108964-A1E74441-197B-4B24-9FF3-8EC4AEBB18C5

Q34108964-A9CA6D8E-42C9-4F6D-8930-3980F5F4FAB3

Q34108964-AFD5482F-7D46-487B-BEDF-9987178AF726

Q34108964-B1217CE4-1B80-4542-BB4B-89A29CBE9DDA

P304

Q34108964-2923B003-4A40-462D-877C-73A195D4C86D

P31

Q34108964-CEDA366C-42FB-4BA8-93BB-8B690C462379

P356

Q34108964-221A42E4-49B7-4134-8E7C-F167FE4E33AF

P433

Q34108964-EC0BD44F-164D-45E3-B06D-3380E9E53441

P478

Q34108964-E051FDB6-6580-4D44-8565-18E3CB8351E5

P50

Q34108964-18CEAF34-6B91-426C-AA27-2E0DEFE8F273

P577

Q34108964-C2C07515-A16F-46A2-8162-C0869F8192B7

P698

Q34108964-A58A1246-62F1-478D-9AEA-35CB3B247013

P932

Q34108964-7C8FAD46-BFF5-48B8-B045-38C2585F234B

P356

J.BBMT.2014.03.033

P1433

Biology of Blood and Marrow Transplantation

P1476

Isolated clonal cytogenetic abnormalities after high-dose therapy

@en

P2093

Constance A Griffin

http://www.w3.org/2001/XMLSchema#string

Hua-Ling Tsai

http://www.w3.org/2001/XMLSchema#string

Katlyn M Briel

http://www.w3.org/2001/XMLSchema#string

Margaret M Showel

http://www.w3.org/2001/XMLSchema#string

Richard J Jones

http://www.w3.org/2001/XMLSchema#string

Robert A Brodsky

http://www.w3.org/2001/XMLSchema#string

P2860

Proposals for the classification of the myelodysplastic syndromes

The origin and evolution of mutations in acute myeloid leukemia

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.

Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.

Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?

Therapy-related myeloid leukemia.

P304

1130-1138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2014.03.033

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Jeanne Kowalski

P577

2014-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24732780

http://www.w3.org/2001/XMLSchema#string

P932

4149219

http://www.w3.org/2001/XMLSchema#string